2 Min WatchArticle17 Oct 2022

Undervalued or Overvalued, Where Do Equities Stand?

At a Glance

In 2022, the rise in bond yields has outpaced the decline in stock prices

The ratio of the S&P 500’s market cap to GDP has fallen from 180% to around 140%

During the first nine months of 2022, the S&P 500 lost a quarter of its value, while the Nasdaq fell by a third. So, are equities now undervalued?

The answer may come as a surprise: by at least one key measure, stocks might be even more overvalued today than they were at the beginning of the year.

To be certain, the ratio of the S&P 500’s market cap to GDP has fallen from 180% to around 140%. By this measure, stocks are indeed less expensive.

But notice that stocks tend to vary inversely with the level of long-term bond yields, and those yields have jumped to their highest level in over a decade.

If one adjusts the S&P 500 market cap GDP ratio by the level of 10-year bond yields, one finds the following: Stocks were cheap compared to bonds back in the 1950s and early 1960s, and the same was true during the 2010s. During these times, stocks vastly outperformed bonds. The opposite was true in the year 2000, when stocks were highly overvalued versus bonds; and between 2000 and 2009, stocks fell sharply versus bonds.

So far this year, the rise in bond yields has outpaced the decline in stock prices. As such, when adjusted for the level of bond yields, stocks actually appear to be at their highest valuation levels since 2007, on the eve of a global financial crisis. As such, unless bond yields begin to decline, it may be premature to call U.S. equities a bargain.

_{OpenMarkets is an online magazine and blog focused on global markets and economic trends. It combines feature articles, news briefs and videos with contributions from leaders in business, finance and economics in an interactive forum designed to foster conversation around the issues and ideas shaping our industry.}

_{All examples are hypothetical interpretations of situations and are used for explanation purposes only. The views expressed in OpenMarkets articles reflect solely those of their respective authors and not necessarily those of CME Group or its affiliated institutions. OpenMarkets and the information herein should not be considered investment advice or the results of actual market experience. Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade. BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.. In the United Kingdom, BrokerTec Europe Limited is authorised and regulated by the Financial Conduct Authority. CME Amsterdam B.V. is regulated in the Netherlands by the Dutch Authority for the Financial Markets (AFM) (www.AFM.nl). CME Investment Firm B.V. is also incorporated in the Netherlands and regulated by the Dutch Authority for the Financial Markets (AFM), as well as the Central Bank of the Netherlands (DNB).}